Laser zaps prostate troubles without cutting
NCT ID NCT07289243
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study compares a new laser procedure (TPLA) to standard surgery (TURP) for men with urinary symptoms caused by an enlarged prostate. Researchers want to see if the laser works just as well, with possibly fewer side effects. About 80 men will take part.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Transperineal laser ablation (TPLA) procedure
- What this could lead to
- If it works, this could offer men a less invasive option for treating urinary symptoms from an enlarged prostate, with similar results to standard surgery.
- What could go wrong
- This is a small, early-stage trial with only 80 participants. The laser may not be as effective as standard surgery, and long-term outcomes are unknown.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BENIGN PROSTATIC OBSTRUCTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
UOC Urologia e Trapianti di Rene Policlinico di Bari
RECRUITINGBari, ITALY/Bari, 70124, Italy
-
UOC Urologia e Trapianti di Rene Policlinico di Bari
ACTIVE_NOT_RECRUITINGBari, ITALY/Bari, 70124, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a precise prostate surgery predict better outcomes? a new study aims to find out.
- New vaginal capsule aims to tackle stubborn bacterial vaginosis
- Can a pill combo spare men from a catheter after a urinary emergency?
- Breakthrough surgery may let men keep ejaculation while treating enlarged prostate
- Gut bacteria boost? new trial combines probiotic with cancer therapy for rectal tumors